Lista de obras - Adam Wysokiński - Dominio Público Uruguay

Affective and Cognitive Verbal Theory of Mind in Schizophrenia: Results From a Novel Paradigm.

artículo científico publicado en 2017

Assessment of cognitive performance using CNS vital signs after electroconvulsive treatment of schizophrenia

artículo científico publicado en 2014

Association between adiposity and fasting serum levels of appetite-regulating peptides: Leptin, neuropeptide Y, desacyl ghrelin, peptide YY(1-36), obestatin, cocaine and amphetamine-regulated transcript, and agouti-related protein in nonobese partic

scientific article published on 01 September 2019

Atherogenic Indices Are Increased in Elderly Patients with Unipolar Depression-Case-Control Analysis.

artículo científico publicado en 2017

BDNF serum levels in schizophrenic patients during treatment augmentation with sarcosine (results of the PULSAR study).

artículo científico publicado en 2016

Biological Motion Sensitivity, But Not Interpersonal Predictive Coding Is Impaired in Schizophrenia.

artículo científico publicado en 2018

Blood levels of glucose and insulin and insulin resistance in patients with schizophrenia on clozapine monotherapy

artículo científico publicado en 2014

Blood serum levels of CART peptide in patients with schizophrenia on clozapine monotherapy

artículo científico publicado en 2014

Body composition does not affect serum levels of cathelicidin LL-37 in elderly women with unipolar depression

artículo científico publicado en 2017

Changes of metabolic parameters during electroconvulsive treatment of schizophrenia: Preliminary results

artículo científico publicado en 2014

Circulating cathelicidin LL-37 level is increased in euthymic patients with bipolar disorder.

artículo científico publicado en 2017

Depressive disorders in the elderly depending on life activity

artículo científico publicado en 2008

Does metabolic status affect serum levels of BDNF and MMP-9 in patients with schizophrenia?

scientific article published on 29 August 2019

Effect of clozapine dose and concentration on fasting concentration of appetite regulating peptides

artículo científico publicado en 2017

Fasting serum leptin levels in elderly women with major depressive disorder: a case-control study

scientific article published on 01 March 2019

Fasting serum levels of neuropeptide y in patients with schizophrenia on clozapine monotherapy

artículo científico publicado en 2015

Homocysteine levels in patients with schizophrenia on clozapine monotherapy

artículo científico publicado en 2013

Human cathelicidin LL-37 - Does it influence the homeostatic imbalance in mental disorders?

artículo científico publicado en 2018

Improvements in body composition, anthropometric measurements and lipid profile following discontinuation of clozapine.

artículo científico publicado en 2015

In schizophrenia serum level of neurotrophin-3 (NT-3) is increased only if depressive symptoms are present

artículo científico publicado en 2018

In vitro cytokine synthesis in unstimulated and mitogen-stimulated peripheral blood mononuclear cells from individuals with schizophrenia

artículo científico publicado en 2019

Intensive electroconvulsive therapy in drug resistant neuroleptic malignant syndrome - case report

artículo científico publicado en 2012

Level of thyroid-stimulating hormone (TSH) in patients with acute schizophrenia, unipolar depression or bipolar disorder

artículo científico publicado en 2014

Levels of C-reactive protein (CRP) in elderly patients with unipolar depression - case control analysis.

artículo científico publicado en 2016

Levels of C-reactive protein (CRP) in patients with schizophrenia, unipolar depression and bipolar disorder

artículo científico publicado en 2014

Levels of triglycerides, cholesterol, LDL, HDL and glucose in patients with schizophrenia, unipolar depression and bipolar disorder.

artículo científico publicado en 2015

MMP-9 Serum Levels in Schizophrenic Patients during Treatment Augmentation with Sarcosine (Results of the PULSAR Study).

artículo científico publicado en 2016

Mechanisms of the anorexia of aging-a review

scientific article published on August 2015

Neutrophil-lymphocyte ratio is increased in elderly patients with first episode depression, but not in recurrent depression.

artículo científico publicado en 2018

No changes of cardiometabolic and body composition parameters after 6-month add-on treatment with sarcosine in patients with schizophrenia.

artículo científico publicado en 2015

Normalization of the Verbal Fluency Test on the basis of results for healthy subjects, patients with schizophrenia, patients with organic lesions of the chronic nervous system and patients with type 1 and 2 diabetes

artículo científico publicado en 2010

Obestatin may be involved in clozapine-induced changes in glucose metabolism.

artículo científico publicado en 2016

PS107. Bone density, muscle mass and body fat in elderly women with depression.

artículo científico publicado en 2016

Persistent penile erection (priapism) associated with quetiapine and lithium

artículo científico publicado en 2015

Platelet parameters (PLT, MPV, P-LCR) in patients with schizophrenia, unipolar depression and bipolar disorder

artículo científico publicado en 2016

Quality of life and emotional functioning in selected cardiovascular diseases.

artículo científico publicado en 2009

Rapidly developing and self-limiting eosinophilia associated with clozapine

scientific article published on 07 July 2014

Red Blood Cells Parameters in Patients with Acute Schizophrenia, Unipolar Depression and Bipolar Disorder

scientific article published on 01 September 2018

Serum folate and homocysteine in chronic schizophrenic patients.

artículo científico publicado en 2017

Serum levels of AgRP protein in patients with schizophrenia on clozapine monotherapy

artículo científico publicado en 2014

Serum levels of PYY(1-36) peptide in patients with schizophrenia on clozapine monotherapy.

artículo científico publicado en 2014

Serum levels of TNF-alpha in patients with chronic schizophrenia during treatment augmentation with sarcosine (results of the PULSAR study)

scientific article published on 10 August 2018

Serum levels of brain-derived neurotrophic factor (BDNF) and neurotrophin-3 (NT-3) in depressed patients with schizophrenia

artículo científico publicado en 2015

Serum levels of desacyl ghrelin in patients with schizophrenia on clozapine monotherapy

artículo científico publicado en 2014

Serum levels of interleukin 6 in schizophrenic patients during treatment augmentation with sarcosine (results of the PULSAR study).

artículo científico publicado en 2018

Serum levels of neuropeptide Y in patients with chronic schizophrenia during treatment augmentation with sarcosine (results of the double-blind randomized controlled PULSAR study)

artículo científico publicado en 2020

Serum levels of peptide cathelicidin LL-37 in elderly patients with depression

artículo científico publicado en 2017

Social cognition in neuropsychiatric populations: a comparison of theory of mind in schizophrenia and mesial temporal lobe epilepsy.

artículo científico publicado en 2017

Successful replacement of electroconvulsive treatment (ECT) with transcranial direct current stimulation (tDCS) in severe, treatment-refractory catatonic schizophrenia: Case study

artículo científico publicado en 2020

Systemic concentration of apelin, but not resistin or chemerin, is altered in patients with schizophrenia

artículo científico publicado en 2020

The association between serum levels of TNF-α and IL-6 in schizophrenic patients and their metabolic status - A case control study

artículo científico publicado en 2020

The expression of toll-like receptors in peripheral blood mononuclear cells is altered in schizophrenia

artículo científico publicado en 2018

The prevalence of metabolic syndrome and Framingham cardiovascular risk scores in adult inpatients taking antipsychotics - a retrospective medical records review

artículo científico

The second agent effect: Interpersonal predictive coding in people with schizophrenia.

artículo científico publicado en 2017

Uric acid levels in patients with schizophrenia on clozapine monotherapy

artículo científico publicado en 2015

XXIV World Allergy Congress 2015

artículo científico publicado en 2016

XXIV World Allergy Congress 2015: Seoul, Korea. 14-17 October 2015

artículo científico publicado en 2016

[Classification of mental disorders of soldiers participating in peace missions and warfare actions].

artículo científico publicado en 2008

[Cognitive functions and depression].

artículo científico publicado en 2009

[Current diagnostic, clinical and therapeutic conceptions of frontotemporal dementia]

artículo científico publicado en 2008

[Diagnostic difficulties linked to frontotemporal dementia--case study].

artículo científico publicado en 2008

[Socio-economic status, aggressive behaviours and coping with stress]

artículo científico publicado en 2009

Lista de obras de Adam Wysokiński

Affective and Cognitive Verbal Theory of Mind in Schizophrenia: Results From a Novel Paradigm.

Assessment of cognitive performance using CNS vital signs after electroconvulsive treatment of schizophrenia

Association between adiposity and fasting serum levels of appetite-regulating peptides: Leptin, neuropeptide Y, desacyl ghrelin, peptide YY(1-36), obestatin, cocaine and amphetamine-regulated transcript, and agouti-related protein in nonobese partic

Atherogenic Indices Are Increased in Elderly Patients with Unipolar Depression-Case-Control Analysis.

BDNF serum levels in schizophrenic patients during treatment augmentation with sarcosine (results of the PULSAR study).

Biological Motion Sensitivity, But Not Interpersonal Predictive Coding Is Impaired in Schizophrenia.

Blood levels of glucose and insulin and insulin resistance in patients with schizophrenia on clozapine monotherapy

Blood serum levels of CART peptide in patients with schizophrenia on clozapine monotherapy

Body composition does not affect serum levels of cathelicidin LL-37 in elderly women with unipolar depression

Changes of metabolic parameters during electroconvulsive treatment of schizophrenia: Preliminary results

Circulating cathelicidin LL-37 level is increased in euthymic patients with bipolar disorder.

Depressive disorders in the elderly depending on life activity

Does metabolic status affect serum levels of BDNF and MMP-9 in patients with schizophrenia?

Effect of clozapine dose and concentration on fasting concentration of appetite regulating peptides

Fasting serum leptin levels in elderly women with major depressive disorder: a case-control study

Fasting serum levels of neuropeptide y in patients with schizophrenia on clozapine monotherapy

Homocysteine levels in patients with schizophrenia on clozapine monotherapy

Human cathelicidin LL-37 - Does it influence the homeostatic imbalance in mental disorders?

Improvements in body composition, anthropometric measurements and lipid profile following discontinuation of clozapine.

In schizophrenia serum level of neurotrophin-3 (NT-3) is increased only if depressive symptoms are present

In vitro cytokine synthesis in unstimulated and mitogen-stimulated peripheral blood mononuclear cells from individuals with schizophrenia

Intensive electroconvulsive therapy in drug resistant neuroleptic malignant syndrome - case report

Level of thyroid-stimulating hormone (TSH) in patients with acute schizophrenia, unipolar depression or bipolar disorder

Levels of C-reactive protein (CRP) in elderly patients with unipolar depression - case control analysis.

Levels of C-reactive protein (CRP) in patients with schizophrenia, unipolar depression and bipolar disorder

Levels of triglycerides, cholesterol, LDL, HDL and glucose in patients with schizophrenia, unipolar depression and bipolar disorder.

MMP-9 Serum Levels in Schizophrenic Patients during Treatment Augmentation with Sarcosine (Results of the PULSAR Study).

Mechanisms of the anorexia of aging-a review

Neutrophil-lymphocyte ratio is increased in elderly patients with first episode depression, but not in recurrent depression.

No changes of cardiometabolic and body composition parameters after 6-month add-on treatment with sarcosine in patients with schizophrenia.

Normalization of the Verbal Fluency Test on the basis of results for healthy subjects, patients with schizophrenia, patients with organic lesions of the chronic nervous system and patients with type 1 and 2 diabetes

Obestatin may be involved in clozapine-induced changes in glucose metabolism.

PS107. Bone density, muscle mass and body fat in elderly women with depression.

Persistent penile erection (priapism) associated with quetiapine and lithium

Platelet parameters (PLT, MPV, P-LCR) in patients with schizophrenia, unipolar depression and bipolar disorder

Quality of life and emotional functioning in selected cardiovascular diseases.

Rapidly developing and self-limiting eosinophilia associated with clozapine

Red Blood Cells Parameters in Patients with Acute Schizophrenia, Unipolar Depression and Bipolar Disorder

Serum folate and homocysteine in chronic schizophrenic patients.

Serum levels of AgRP protein in patients with schizophrenia on clozapine monotherapy

Serum levels of PYY(1-36) peptide in patients with schizophrenia on clozapine monotherapy.

Serum levels of TNF-alpha in patients with chronic schizophrenia during treatment augmentation with sarcosine (results of the PULSAR study)

Serum levels of brain-derived neurotrophic factor (BDNF) and neurotrophin-3 (NT-3) in depressed patients with schizophrenia

Serum levels of desacyl ghrelin in patients with schizophrenia on clozapine monotherapy

Serum levels of interleukin 6 in schizophrenic patients during treatment augmentation with sarcosine (results of the PULSAR study).

Serum levels of neuropeptide Y in patients with chronic schizophrenia during treatment augmentation with sarcosine (results of the double-blind randomized controlled PULSAR study)

Serum levels of peptide cathelicidin LL-37 in elderly patients with depression

Social cognition in neuropsychiatric populations: a comparison of theory of mind in schizophrenia and mesial temporal lobe epilepsy.

Successful replacement of electroconvulsive treatment (ECT) with transcranial direct current stimulation (tDCS) in severe, treatment-refractory catatonic schizophrenia: Case study

Systemic concentration of apelin, but not resistin or chemerin, is altered in patients with schizophrenia

The association between serum levels of TNF-α and IL-6 in schizophrenic patients and their metabolic status - A case control study

The expression of toll-like receptors in peripheral blood mononuclear cells is altered in schizophrenia

The prevalence of metabolic syndrome and Framingham cardiovascular risk scores in adult inpatients taking antipsychotics - a retrospective medical records review

The second agent effect: Interpersonal predictive coding in people with schizophrenia.

Uric acid levels in patients with schizophrenia on clozapine monotherapy

XXIV World Allergy Congress 2015

XXIV World Allergy Congress 2015: Seoul, Korea. 14-17 October 2015

[Classification of mental disorders of soldiers participating in peace missions and warfare actions].

[Cognitive functions and depression].

[Current diagnostic, clinical and therapeutic conceptions of frontotemporal dementia]

[Diagnostic difficulties linked to frontotemporal dementia--case study].

[Socio-economic status, aggressive behaviours and coping with stress]